Publications
Dunseath GJ, Bright D, Luzio SD. Comparative Accuracy Evaluation of a Blood Glucose Meter With Novel Hematocrit Correction Technology, With Three Currently Used Commercially Available Blood Glucose Monitoring Systems. J Diabetes Sci Technol. 2019 Jan 9:1932296818821389. doi: 10.1177/1932296818821389. [Epub ahead of print]. PMID: 30623673
Verma S, Poulter NR, Bhatt DL, Bain SC, Buse JB, Leiter LA, Nauck MA, Pratley RE, Zinman B, Ørsted DD, Monk Fries T, Rasmussen S, Marso SP. Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke. Circulation. 2018 Dec 18;138(25):2884-2894. doi: 10.1161/CIRCULATIONAHA.118.034516. PMID: 30566004
Eckstein ML, Williams DM, O'Neil LK, Hayes J, Stephens JW, Bracken RM. Physical exercise and non-insulin glucose-lowering therapies in the management of Type 2 diabetes mellitus: a clinical review. Diabet Med. 2018 Dec 7. doi: 10.1111/dme.13865. [Epub ahead of print] Review. PMID: 30536728
Gilbert MP, Bain SC, Franek E, Jodar-Gimeno E, Nauck MA, Pratley R, Réa RR, Kerr Saraiva JF, Rasmussen S, Tornøe K, von Scholten BJ, Buse JB; and the LEADER Publication Committee on behalf of the LEADER Trial Investigators. Effect of liraglutide on cardiovascular outcomes in elderly patients: post hoc analysis of a randomized controlled trial. Ann Intern Med. 2018 Dec 4. doi: 10.7326/M18-1569. [Epub ahead of print] No abstract available. PMID: 30508430
McCarthy O, Bain SC, Deere R. Basal insulin reductions in anticipation of multiple exercise sessions in people with type 1 diabetes-a clinical perspective. Ann Transl Med. 2018 Dec;6(Suppl 2):S111. doi: 10.21037/atm.2018.11.63. No abstract available. PMID: 30740432.
Di Battista EM, Bracken RM, Stephens JW, Rice S, Williams SP, Thomas M, Mellalieu SD. Cardiovascular risk assessments at occupational health services: employee experiences. Occup Med (Lond). 2018 Nov 26. doi: 10.1093/occmed/kqy156. [Epub ahead of print]. PMID: 30476220
Owens DR, S Bailey T, Fanelli C, Yale JF, Bolli GB. Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) - a review of evidence and clinical interpretation. Diabetes Metab. 2018 Nov 26. pii: S1262-3636(18)30219-2. doi: 10.1016/j.diabet.2018.11.004. [Epub ahead of print] Review. PMID: 30496834
Bhattacharjee D, Vracar S, Round RA, Nightingale PG, Williams JA, Gkoutos GV, Stratton IM, Parker R, Luzio SD, Roberts GA, Webber J, Ghosh S, Manley SE. Utility of HbA1c assessment in people with diabetes awaiting liver transplantation. Diabet Med. 2018 Nov 26. doi: 10.1111/dme.13870. [Epub ahead of print]. PMID: 30474191
Fulcher G, Mehta R, Fita EG, Ekelund M, Bain SC. Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials. Diabetes Ther. 2018 Nov 24. doi: 10.1007/s13300-018-0531-0. [Epub ahead of print].PMID: 30474818
Churm R, Caplin S, Barry J, Davies JS, Stephens JW, Prior SL. Acyl-ghrelin mediated lipid retention and inflammation in obesity-related Type 2 diabetes. Mol Cell Endocrinol. 2018 Nov 12. pii: S0303-7207(18)30322-8. doi: 10.1016/j.mce.2018.11.004. [Epub ahead of print]. PMID: 30439508